Lv3
340 积分 2024-09-12 加入
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial
12天前
已完结
Progress through Persistence — Turning the Page in Pulmonary Fibrosis Clinical Trials
12天前
已完结
Six highlights from lung-health research
21天前
已完结
The structural basis for the selective antagonism of soluble TNF-alpha by shark variable new antigen receptors
1个月前
已完结
How multispecific molecules are transforming pharmacotherapy
2个月前
已完结
New Insights into the Pathogenesis of Psoriatic Arthritis
4个月前
已完结
Primary Biliary Cholangitis: Personalizing Second-Line Therapies-R1
4个月前
已完结
Emerging Therapeutics for Primary Biliary Cholangitis
4个月前
已关闭
Lupus Nephritis: Current Perspectives and Moving Forward
5个月前
已完结
The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment
5个月前
已完结
皖公网安备34019202002308
